We are live on ! Find out more
EPZM

Epizyme, Inc

Delisted

EPZM was delisted on the 11th of August, 2022.

89 hedge funds and large institutions have $543M invested in Epizyme, Inc in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 27 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more call options, than puts

Call options by funds: $93K | Put options by funds: $45K

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

17% more capital invested

Capital invested by funds: $465M → $543M (+$78.2M)

0% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 27

9% less funds holding

Funds holding: 9889 (-9)

45% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 20

Holders
89
Holders Change
-9
Holders Change %
-9.18%
% of All Funds
2.33%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
11
Increased
27
Reduced
27
Closed
20
Calls
$93K
Puts
$45K
Net Calls
+$48K
Net Calls Change
+$1.52M
Name Holding Trade Value Shares
Change
Change in
Stake
SIP
101
Stoneridge Investment Partners
Pennsylvania
-$677K -52,625 Closed
GPCM
102
Granite Point Capital Management
Massachusetts
-$579K -45,000 Closed
HT
103
HAP Trading
New York
-$317K -24,670 Closed
SEI Investments
104
SEI Investments
Pennsylvania
-$198K -15,372 Closed
PG
105
PEAK6 Group
Illinois
-$156K -12,164 Closed
Jane Street
106
Jane Street
New York
-$144K -11,187 Closed
DAM
107
Doheny Asset Management
California
-$142K -11,050 Closed
QT
108
Quantbot Technologies
New York
-$136K -10,648 Closed

EPZM Hedge Fund Activity: Q4 2015 in Review

89 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2015, worth a combined $543M — up 17% from $465M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of EPZM and 11 opened new positions — a net loss of 9 holders — while 27 trimmed existing stakes and 27 added.

The largest buyer was Jennison Associates, adding an estimated $9.49M. The largest seller was EcoR1 Capital, cutting an estimated $11.8M.

  • 89 institutional investors held Epizyme, Inc (EPZM) as of Q4 2015, down from 98 in Q3 2015.
  • Funds reported $543M of Epizyme, Inc stock for Q4 2015, up 17% quarter-over-quarter.
  • 11 funds opened new Epizyme, Inc positions in Q4 2015 and 20 closed out, a net change of -9 holders.
  • The largest Epizyme, Inc buyer in Q4 2015 was Jennison Associates, an estimated $9.49M added.
  • The largest Epizyme, Inc seller in Q4 2015 was EcoR1 Capital, an estimated $11.8M sold.

Based on aggregated 13F filings for Q4 2015.